Top Healthcare Stocks
Healthcare stocks are narrowly mixed with the NYSE Healthcare
Sector Index climbing about 0.3% while shares of healthcare
companies in the S&P 500 also rising 0.3% as a group.
In company news, Intercept Pharmaceuticals Inc. (
) rallied for a fourth day in a row, supported today by analysts at
Janney Capital raising its price target for the biopharmaceutical
stock to $300 from $55 a share.
The stock more than tripled during Thursday's session after
regulators ended testing of the company's obeticholic acid for the
treatment of nonalcoholic steatohepatitis early after an interim
analysis showed it already met the primary endpoint.
Shares were up 62% just before the close at $447.10 each,
reaching an intraday high of $497.00.
(+) IMMU, (+14.7%) First patient receives dosing in Phase III
trial of the company's yttrium 90-clivatuzumab tetraxetan drug
candidate combined with low-dose gemcitabine in patients with
metastatic pancreatic cancer who received two prior treatments.
(-) AEGR, (-12.4%) Receives Justice Department subpoena seeking
documents about the drug-maker's sales of its Juxtapid cholesterol
medication. Forecasts FY13 net product sales of $48 mln to $49 mln,
trailing analyst consensus by at least $780,000.
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.